Linfomas
Pérez-Aguilera, M, Pedrosa, L, Gómez, S, Salazar-Ortego, S, Fernández-Miranda, I, Muñoz-Viana, R, Martín-Acosta, P, Martín-Lunas, BL, Jimeno, R, Yanguas-Casás, N, Horcajo, B, Roncador, G, Martínez-Climent, JA, Ortega-Molina, A, Sánchez-Beato, M
"Decoding the Heterogeneity of Diffuse Large B-Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B-Cell Lymphoma Cell Lines".
Hematol. Oncol.. 44(5): e70228. 2026. [doi:10.1002/hon.70228]
Corral, LL, Canales, MA, García-Sancho, AM, Serrano, JD, Díez, B, Sancho, SII, de Cerio, ALD, Rodríguez-Madoz, JR, Yañez, RM, Grande, C, Martín-López, AA, Pérez-López, E, López-Parra, M, Gutiérrez, NC, Villarón, EM, Navarro-Bailón, A, Espuch, JG, Cornago, J, Musseti, A, López-Franco, E, Pérez-Simón, JA, Bueren, J, Sánchez-Guijo, F, Prósper, F
"Phase I/IIA multicenter trial of non-viral sleeping beauty transposon-engineered CD19 CAR-T cells (TranspoCART19) in relapsed/refractory B-cell lymphomas: results from dose levels 1 and 2".
Bone Marrow Transplant.. 61: 39 - 41. 2026.
Gonzalez, C, Garces, JJ, Gracia, H, Guerrero, C, D'Agostino, M, Medina-Herrera, A, Nuvolone, M, Puig, N, Cedena, MT, Lasa, M, Alignani, D, Lopez, A, Sarvide, S, Aguirre-Ruiz, P, Lamo-Espinosa, JM, Prosper, F, Rodriguez-Otero, P, Martinez-Climent, JA, Lattarulo, F, Nevone, A, Massa, M, Palladini, G, Bertuglia, G, Gay, F, Rosiñol, L, García-Sanz, R, Martinez-Lopez, J, Mateos, MV, Lahuerta, JJ, Bladé, J, San-Miguel, JF, Paiva, B
"Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers".
Blood Cancer Discov.. 7(4): 558 - 571. 2026. [doi:10.1158/2643-3230.BCD-25-0102]
Cenzano, I, Cocera, M, Larrayoz, M, Campos-Dopazo, L, Sanz, S, Bantan, A, Vilas-Zornoza, A, San-Martin, P, Aguirre-Ruiz, P, Alignani, D, Lopez, A, Gonzalez, IS, Ruiz, J, Ripalda-Cemborain, P, Abengozar-Muela, M, Muiños-López, E, Lagani, V, Tegner, J, Hernáez, M, Agirre, X, Ebert, B, Paiva, B, Rodriguez-Otero, P, Tamariz-Amador, LE, San-Miguel, J, Saez, B, Martinez-Climent, JA, Calvo, IA, Gomez-Cabrero, D, Prosper, F
"Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response".
Nat. Commun.. 17(1): 7893. 2026. [doi:10.1038/s41467-026-74389-y]
Hutchings, M, Zelenetz, AD, Christensen, JH, Hernandez, AC, Assouline, SE, Castillo, LEM, Kothari, S, Modi, D, Albendea, MAC, Cubillas, D, Garcia-Sancho, AM, Diefenbach, CS, Kuruvilla, J, Caimi, PF, Patel, K, Landrette, S, Zhi, X, Zhang, YY, Meier, R, Matasar, M
"Phase 1 study of ARV-393, a PROTAC BCL6 degrader, as monotherapy in patients with advanced non-Hodgkin lymphoma (NHL) or combined with glofitamab in patients with diffuse large B-cell lymphoma (DLBCL).".
J. Clin. Oncol.. 44(16_SUPPL): 7103 - 7103. 2026. [doi:10.1200/JCO.2026.44.16_suppl.TPS7103]
Hutchings, M, Zelenetz, A, Christensen, JH, Hernandez, AC, Assouline, S, Castillo, LEM, Kothari, S, Modi, D, Albendea, MAC, Cubillas, D, Garcia-Sancho, AM, Diefenbach, CM, Kuruvilla, J, Caimi, PF, Patel, K, Landrette, S, Zhi, ER, Zhang, YY, Meier, R, Matasar, MJ
"Phase 1 study of ARV-393, a PROTAC BCL6 degrader, as monotherapy in patients with advanced non-Hodgkin lymphoma (NHL) or combined with glofitamab in patients with diffuse large B-cell lymphoma (DLBCL)".
Cancer Res.. 86(8): CT268. 2026. [doi:10.1158/1538-7445.AM2026-CT268]
Huerga-Domínguez, S, Ariceta, B, Aguirre-Ruiz, P, San Martín-Uriz, P, Sarvide, S, López-Janeiro, A, Alignani, D, López, A, Ezponda, T, Figueroa, R, Grande, C, Alfonso, A, Pena, E, Browne, S, Robledano, R, Vilas-Zornoza, A, Roa, S, Martínez-Climent, JA, Prósper, F, Canales, M
"Integrated Single-Cell and Spatial Multi-Omics of Clonal Precursors and Immune Niches in Germinal Center Lymphomas".
Cancers. 18(7): 1122. 2026. [doi:10.3390/cancers18071122]
Panizo-Inogés, M, Marcos-Jubilar, M, González-Porras, JR, Puerta-Vazquez, C, Fernández-Arias, C, Rodríguez-Otero, P, Alfonso-Pierola, A, Villar, S, Canales, MA, Orbe, J, Páramo, JA, Prósper, F, Lecumberri, R
"Haemostatic changes during CART cell therapy and risk of complications".
Cancer Immunol. Immunother.. 75(4): 130. 2026. [doi:10.1007/s00262-026-04371-6]
Iacoboni, G, Kyvsgaard, ER, Garces, VN, Russler-Germain, DA, Lewis, K, Garcia-Sancho, AM, Carro, I, Thompson, PA, Therwhanger, D, Quintela, D, Ku, M, Gomez, P, Valencia, E, Vega, G, Jimenez-Ubieto, A, Bastos-Oreiro, M, Serna, A, Husby, S, De La Cruz, B, Luan, J, Camarillas, S, Medina, L, Cabero, A, Cordoba, R, Canales, M, Sancho, JM, Bosch, F, Sureda, A, Schuster, S, Cheah, CY, Hutchings, M, Barba, P, Abrisqueta, P
"Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma".
Blood Adv.. 10(6): 1947 - 1951. 2026. [doi:10.1182/bloodadvances.2025018546]
Jelinek T, Žihala D, Zabaleta A, Kostopoulos IV, Soucek O, Venglar O, Moreno C, Fotiou D, Radova E, Tamariz-Amador LE, Theodorakakou F, Muronova L, Manubens A, Tsitsilonis O, Popková T, Gonzalez C, Anilkumar Sithara A, Corrado F, Bidikian N, Guerrero C, Kapustova V, Bilek D, Hagner PR, Larrayoz M, Martínez-Climent JA, Broskevicová L, Mihalyova J, Merz M, Sevcikova T, Ghobrial IM, San-Miguel JF, Dimopoulos MA, Rodriguez-Otero P, Radocha J, Kastritis E, Paiva B, Hajek R
"Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.".
Blood. 147(10). 2026. [doi:10.1182/blood.2025029572]
|